|1.||Kurup, Parameswara Achutha: 32 articles (03/2012 - 04/2002)|
|2.||Kurup, Ravi Kumar: 30 articles (12/2003 - 04/2002)|
|3.||Ahmed, Ali: 20 articles (05/2014 - 02/2002)|
|4.||Gheorghiade, Mihai: 18 articles (06/2015 - 01/2002)|
|5.||Kurup, P A: 18 articles (06/2003 - 05/2000)|
|6.||Aronow, Wilbert S: 14 articles (05/2013 - 03/2002)|
|7.||Dasgupta, Amitava: 11 articles (05/2012 - 03/2002)|
|8.||van Veldhuisen, Dirk J: 10 articles (05/2014 - 03/2002)|
|9.||Semenza, Gregg L: 10 articles (03/2014 - 12/2008)|
|10.||Fonarow, Gregg C: 7 articles (06/2015 - 01/2012)|
03/09/2004 - "Digoxin, which is one of the most commonly prescribed drugs for the treatment of heart failure, is mainly eliminated from the circulation by the kidney. "
04/01/1989 - "Thus, digoxin therapy is associated with a significant improvement in exercise capacity in patients with chronic heart failure, most likely due to an improved matching of ventilation to perfusion."
04/01/2009 - "Digoxin is an important therapeutic agent for the treatment of congestive cardiac failure. "
11/15/2008 - "Previous trials have shown that digoxin was beneficial in patients with heart failure (HF). "
01/01/2009 - "Digoxin is an agent that is readily available, can be administered acutely and long-term, intravenously or orally, is safe and may be beneficial in both acute and chronic heart failure (HF). "
10/01/2001 - "The first of the above adjustment methods would lead to good results if digoxin has not been prescriped in order to control the cardiac frequency in the setting of auricular fibrillation."
10/01/1992 - "In patients with atrial fibrillation digoxin is beneficial for ventricular rate control. "
12/16/2003 - "Digoxin is only effective for rate control at rest and therefore should only be used as a second-line agent for rate control in atrial fibrillation. "
01/01/1994 - "The use of digoxin remains a mainstay of treatment for rate control in atrial fibrillation. "
04/01/1987 - "to determine whether digoxin is effective in converting atrial fibrillation of recent onset to normal sinus rhythm. "
05/01/1996 - "Digoxin-specific Fab are recognized to be effective in the treatment of acute cardiac glycoside poisoning but no pharmacokinetic studies have been performed in human volunteers. "
09/01/2014 - "There were no randomised clinical trials examining the use of digoxin-Fab for acute or chronic digoxin poisonings. "
10/01/1980 - "Study of the correlations between the serum digoxin level of poisoning and some clinico-functional variables in a sample of 40 poisoned patients]."
09/01/1979 - "[Pharmacodynamic studies in suicidal digoxin poisoning (author's transl)]."
09/01/2014 - "With chronic poisoning, it may be simplest to give 40 mg (1 vial) digoxin-Fab at a time and repeat after 60 min if there is no response."
02/01/1985 - "This study demonstrates that digoxin was effective in preventing significant spontaneous recurrences of supraventricular tachycardia in only 8/18 (44%) infants treated with digoxin. "
11/01/2001 - "Digoxin has been an effective treatment for fetal supraventricular tachycardia (SVT), but second-line therapy remains more controversial. "
10/01/1995 - "Comparison with previous natural history studies suggests that digoxin is ineffective in the prophylaxis of supraventricular tachycardia. "
04/01/1989 - "This study was conducted to ascertain if critical peak body stores of digoxin were needed to protect patients from the debilities that result from supraventricular tachycardias occurring after open heart operations. "
04/01/2005 - "Transplacental digoxin therapy successfully converted the supraventricular tachycardia to a normal sinus rhythm without evidence of maternal or fetal side-effects. "
|5.||Cardiac Arrhythmias (Arrythmia)
05/01/2006 - "Early recognition that an arrhythmia is related to digoxin intoxication as well as recognition of concomitant medications or medical conditions that may directly alter the pharmacokinetic profile of digoxin, or indirectly alter its cardiac effects by pharmacodynamic interactions remain essential for safe and effective use of digoxin in patients with AF."
08/01/2010 - "WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT * Increased frequency of electrolyte abnormalities and cardiac arrhythmias among patients exposed to digoxin-diuretic interactions has been well-documented in numerous descriptive studies. "
03/18/2000 - "After a preliminary dose-finding study, 66 patients who presented to hospital with a serious cardiac arrhythmia were randomised to receive either 1200 mg of anti-digoxin Fab or a saline placebo. "
01/01/1992 - "An open, controlled randomised prospective clinical study of 111 patients was undertaken to compare the incidence of cardiac arrhythmias in the 58 patients who received preoperative digoxin and the 53 who did not. "
03/01/1985 - "This study was initiated to determine if ventricular arrhythmia induced by digoxin was associated with a nonuniform neural discharge in the cardiac sympathetic postganglionic fibers. "
|2.||Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)
|6.||Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
|9.||Immunoglobulin Fab Fragments
|1.||Drug Therapy (Chemotherapy)
|2.||Electric Countershock (Cardioversion)
|5.||Chelation Therapy (Therapy, Chelation)